About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
504
By Phase
PHASE1: 5EARLY_PHASE1: 1PHASE2: 1
By Status
COMPLETED: 5ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06988553Lead Sponsor
A Phase Ib Study of AZD5004 in Chinese Participants With Overweight/Obesity With or Without Type 2 Diabetes Mellitus
PHASE1Active, not recruiting
45 participants
Started: Jun 17, 2025 · Completed: Dec 31, 2025
NCT06293742Lead Sponsor
ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants
PHASE1Completed
48 participants
Started: Feb 8, 2024 · Completed: Apr 15, 2024
NCT06268145Lead Sponsor
ECC5004 RBA FE Study in Healthy Participants
PHASE1Completed
14 participants
Started: Feb 6, 2024 · Completed: Mar 29, 2024
NCT05654831Lead Sponsor
FTIH of ECC5004 in Healthy and Diabetic Participants
PHASE1Completed
69 participants
Started: Dec 1, 2022 · Completed: Nov 1, 2023
NCT05552274Lead Sponsor
FTIH of ECC4703 in Healthy Volunteers
EARLY_PHASE1Completed
75 participants
Started: Aug 16, 2022 · Completed: Oct 26, 2023
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...